EPHA2 and neoplasm: Mass spectrometry analysis demonstrated that the E3 ligase RNF5 directly interacted with EphA2 and induced EphA2 ubiquitination and degradation in HER2-negative breast cancer cells [32], thereby suppressing EphA2 tumor-suppressive functions in this neoplasia.